AccuMeasure
Deviceintracolonoscopy measurement of polyps using a laser-based device
Other names: laser-based polyp measurement
NCT Number: NCT05489380
Recent updates of the guidelines on polyp surveillance of the American Society of Gastrointestinal Endoscopy (ASGE) and European Society of Gastrointestinal Endoscopy (ESGE) increasingly focus on size of polyps as an important indicator of malignant transformation to colorectal cancer (CRC). However, the interobserver variability in polyp size assessment between optical diagnosis of endoscopists and pathologists is considerable. This may lead to incorrect surveillance intervals in patients at risk for developing colorectal cancer, which may increase the risk of post-colonoscopy CRC (PCCRC). This study aims to assess the precision of a new laser-based measurement system (AccuMeasure, VTM Technologies Ltd.) for polyps during colonoscopy.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Radboud university medical center, Nijmegen, Gelderland, Netherlands
Objective: The main objective is to compare the precision of polyp size measurement by AccuMeasure to biopsy forceps assisted measurement. Secondary objectives are to assess: Time needed for measurement and learning curve, endoscopists advised surveillance intervals based on both measurement methods, and safety.
Study design: Multicenter, randomized, parallel group, endoscopist blinded study, including the measurement of 138 polyps during standard colonoscopy. With a polyp detection rate of approximately 40%1, this results in up to 345 patients/colonoscopies to be included. Enrollment will conclude once 138 polyps are included in the study.
Study population: All adult patients with screening or surveillance colonoscopies will be asked for informed consent. Polyps smaller than 25mm found during colonoscopy are considered eligible for inclusion. Up to 3 polyps per patient can be included in this study.
Intervention: Optical assessment will be performed upon identification of the polyp. Then, measurement with AccuMeasure and biopsy forceps will be performed in a randomized order. The endoscopist will remain blinded to the AccuMeasure measurement outcomes, to avoid a learning effect that could influence subsequent measurements.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
intracolonoscopy measurement of polyps using a laser-based device
Other names: laser-based polyp measurement
Time frame: at colonoscopy
interobserver agreement between AccuMeasure and biopsy forceps assisted measurement
Time frame: 30 days post colonoscopy
Number of Participants with adverse events
Time frame: at colonoscopy
Size differences for optical/biopsy forceps/AM assessment as compared to pathology size measurement;
Time frame: at colonoscopy
Time for measurement with AccuMeasure related to number of measurements performed
Time frame: At colonoscopy
Endoscopist advised surveillance interval based on optical assessment during colonoscopy, on measurement with an open biopsy forceps, and on measurement with AccuMeasure
Time frame: at colonscopy
method of polyp removal, i.e., polypectomy, endoscopic mucosal resection, endoscopic submucosal dissection
Time frame: at colonoscopy
Boston bowel preparation scale score (BBPS), in which segmental scores of 0 are worst and scores of 3 are best (completely clean)
Radboud University Medical Center
Other
Optical Diagnosis Versus Laser Measurement of Polyps' Size During Colonoscopy and Implications for Surveillance (Polyp Size Study)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05545787
Colorectal Polyp
Beijing, Beijing Municipality, China
View Trial DetailsNCT06791395
Colonic Diseases, Colorectal Neoplasms
Changchun, Jilin, China
View Trial DetailsNCT07517848
Colo-rectal Cancer, Colonic Diseases
Manisa, Turkey (Türkiye)
View Trial DetailsNCT05220345
Adenoma, Artificial Intelligence
Nijmegen, Gelderland, Netherlands
View Trial Details